Relmada Therapeutics (RLMD) Other Non-Current Assets (2014 - 2026)
Relmada Therapeutics' Other Non-Current Assets was $19,500 in Q2 2026, down 11.3% from $21,975 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Other Non-Current Assets (2014 - 2026) Analysis & Trends
From Q4 2014 onward, Relmada Therapeutics has reported Other Non-Current Assets for 28 quarters.
- Other Non-Current Assets shows a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $21,975 in FY2024 (-49.0%), $43,125 in FY2023 (+23.7%), $34,875 in FY2022 (+23.3%) and $28,293 in FY2021 (+13.2%).
- Quarterly Other Non-Current Assets has moved between $16,095 (Q3 2022) and $493,452 (Q3 2023) over five years.
- Compared with a year earlier, Other Non-Current Assets has declined for three straight quarters, with an average decline of 35.8% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q2 2022 (growth of 41.0%); the worst was Q3 2024 (a decline of 95.5%).
- Per Business Quant data, RLMD's Other Non-Current Assets in the three quarters before Q2 2026 was $19,500 (Q1 2026), $19,500 (Q4 2025) and $21,975 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | 19,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,500.00 |
| Mar 31, 2026 | 19,500.00 |
| Dec 31, 2025 | 19,500.00 |
| Sep 30, 2025 | 21,975.00 |
| Jun 30, 2025 | 21,975.00 |
| Mar 31, 2025 | 21,975.00 |
| Dec 31, 2024 | 21,975.00 |
| Sep 30, 2024 | 21,975.00 |
| Jun 30, 2024 | 53,625.00 |
| Mar 31, 2024 | 43,125.00 |
| Dec 31, 2023 | 43,125.00 |
| Sep 30, 2023 | 493,452.00 |
| Jun 30, 2023 | 493,452.00 |
| Mar 31, 2023 | 493,452.00 |
| Dec 31, 2022 | 34,875.00 |
| Sep 30, 2022 | 16,095.00 |
| Jun 30, 2022 | 35,238.00 |
| Mar 31, 2022 | 28,293.00 |
| Dec 31, 2021 | 28,293.00 |
| Sep 30, 2021 | 25,000.00 |
API Access
Relmada Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();